Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Rolin L. Wade's publication output changed over time?
ScholarIQpublication output · 2005–2021
Output grew100% over the shown period — from 1 works in 2005 to 2 in 2021.
1
1
2
1
1
2
1
2
20052013201620172018201920202021
What are the most-cited papers on Rolin L. Wade?
ScholarIQmost cited works
Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex
Rolin L. Wade, Paresh Chaudhari, Jaime L. Natoli, Robert J. Taylor, Brian H. Nathanson, David L. Horn
S80485324. 201359 Citations
Enzymes of drug metabolism during delirium
Susan V. White, Brian L. Calver, Vicky Newsway, Rolin L. Wade, Sarju Patel, Antony Bayer, M. S. O'Mahony
Age and Ageing. 200546 CitationsOPEN ACCESS
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Dionne M. Hines, Pallavi Rane, Jeetvan Patel, David J. Harrison, Rolin L. Wade
Vascular Health and Risk Management. 201843 CitationsOPEN ACCESS
<p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>
Dionne M. Hines, Yao Ding, Rolin L. Wade, Anne Beaubrun, Joshua Cohen
Patient Preference and Adherence. 201941 CitationsOPEN ACCESS
Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007–18
Victoria Divino, Mitch DeKoven, Michael Kleinrock, Rolin L. Wade, Satyin Kaura
S4210185023. 201638 CitationsOPEN ACCESS
Related on ScholarIQ
IQVIA (United States)
Institution
Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex
Paper
Enzymes of drug metabolism during delirium
Paper
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Paper
<p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>
Paper
Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007–18
Paper